Today, most pharmaceutical companies see oncology medications as their best hope for big future earnings, as these drugs have big pricetags and offer unique benefits. In the future, however, some companies may refuse to pay these prices, notes sister publication FiercePharma. In fact, pharmas are already beginning to slash the price of some cancer drugs, as they're well aware that insurance companies won't pay as much as $100,000 for six months of life for much longer. FiercePharma